Quick Answer
Oscar Health, Inc. reported Long Term Debt of $430.10 million for the year ending 2025.
- Oscar Health, Inc. showed an increase of +43.6% in Long Term Debt from 2024 to 2025.
- This data is from Oscar Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00 | Q1 2022: $297.42 million | Q2 2022: $297.61 million | Q3 2022: $297.81 million | Q1 2023: $298.19 million | Q2 2023: $298.39 million | Q3 2023: $298.58 million | Q1 2024: $298.97 million | Q2 2024: $299.17 million | Q3 2024: $299.36 million | Q1 2025: $299.75 million | Q2 2025: $299.94 million | Q3 2025: $686.29 million.
- Over the full 6 years of available data (2020 to 2025), Oscar Health, Inc.'s Long Term Debt has grown by 201.8%.
- Historical annual values: Fiscal year 2025: $430.10 million | Fiscal year 2024: $299.56 million | Fiscal year 2023: $298.78 million | Fiscal year 2022: $298.00 million | Fiscal year 2021: $0.00 | Fiscal year 2020: $142.49 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: